Cloverfields Capital Group’s Novo Nordisk NVO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q4 | – | Sell |
|
|||||
|
2025
Q3 | $2.02M | Sell |
|
|||||
|
2025
Q2 | $2.74M | Buy |
|
|||||
|
2025
Q1 | $1.82M | Buy |
|
|||||
|
2024
Q4 | $2.23M | Buy |
|
|||||
|
2024
Q3 | $2.74M | Sell |
|
|||||
|
2024
Q2 | $3.82M | Buy |
|
|||||
|
2024
Q1 | $3.4M | Buy |
|
|||||
|
2023
Q4 | $2.71M | Sell |
|
|||||
|
2023
Q3 | $2.58M | Hold |
|
|||||
|
2023
Q2 | $2.29M | Buy |
|
|||||
|
2023
Q1 | $1.45M | Buy |
|
|||||
|
2022
Q4 | $702K | Sell |
|
|||||
|
2022
Q3 | $833K | Buy |
|
|||||
|
2022
Q2 | $924K | Sell |
|
|||||
|
2022
Q1 | $937K | Sell |
|
|||||
|
2021
Q4 | $1.18M | Hold |
|
|||||
|
2021
Q3 | $1.01M | Buy |
|
|||||
|
2021
Q2 | $873K | Buy |
|
|||||
|
2021
Q1 | $694K | Buy |
|
|||||
|
2020
Q4 | $709K | Buy |
|